Literature DB >> 7844077

Pneumonia in the elderly.

M Woodhead1.   

Abstract

However it is assessed, pneumonia is more important in the elderly than in any other age group. For community acquired or nosocomial pneumonia elderly adults far exceed any other age group with 97% of all pneumonia deaths occurring in this age group. Increasingly pneumonia in the immunocompromised elderly is also being seen. The factors which determine the increased frequency of pneumonia in the elderly include social effects, immune changes and physiological changes in the lungs. These are compounded by the effects of the high frequency of chronic disease in this group. The clinical presentation of pneumonia is slightly different in the elderly and this, together with the presence of underlying disease, may make diagnosis difficult; however, focal signs in the chest are nearly always present. Streptococcus pneumoniae is the most important cause of community acquired pneumonia in the elderly followed by Haemophilus influenzae and the influenza viruses. In contrast to younger adults Mycoplasma pneumoniae infection is rarely identified. The role of Gram-negative enterobacteria is unclear, with some studies suggesting that this is the most frequent pathogen, others finding no cases at all. The pathogens causing nosocomial pneumonia are similar to those in younger adults. Management is more difficult because of the effects of underlying diseases, altered drug pharmacokinetics and drug interactions and the outcome is significantly worse with 25% of adults with community acquired pneumonia dying in recent prospective studies.

Entities:  

Mesh:

Year:  1994        PMID: 7844077     DOI: 10.1093/jac/34.suppl_a.85

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  10 in total

Review 1.  The pulmonary physician in critical care . 3: critical care management of community acquired pneumonia.

Authors:  S V Baudouin
Journal:  Thorax       Date:  2002-03       Impact factor: 9.139

2.  Community-Acquired Pneumonia: An Overview.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-04       Impact factor: 3.725

3.  Community acquired pneumonia in elderly people. Current British guidelines need revision.

Authors:  S J Wort; T R Rogers
Journal:  BMJ       Date:  1998-06-06

4.  Rapid detection of penicillin-resistant Streptococcus pneumoniae in cerebrospinal fluid by a seminested-PCR strategy.

Authors:  M du Plessis; A M Smith; K P Klugman
Journal:  J Clin Microbiol       Date:  1998-02       Impact factor: 5.948

Review 5.  Cefixime. A review of its therapeutic efficacy in lower respiratory tract infections.

Authors:  A Markham; R N Brogden
Journal:  Drugs       Date:  1995-06       Impact factor: 9.546

6.  [Update to the Latin American Thoracic Association (ALAT) recommendations on community acquired pneumonia].

Authors: 
Journal:  Arch Bronconeumol       Date:  2004-08       Impact factor: 4.872

Review 7.  Improving outcomes of elderly patients with community-acquired pneumonia.

Authors:  Félix Gutiérrez; Mar Masiá
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

Review 8.  Sparfloxacin. A review of its antibacterial activity, pharmacokinetic properties, clinical efficacy and tolerability in lower respiratory tract infections.

Authors:  K L Goa; H M Bryson; A Markham
Journal:  Drugs       Date:  1997-04       Impact factor: 9.546

Review 9.  Lung infections and aging.

Authors:  Keith C Meyer
Journal:  Ageing Res Rev       Date:  2004-01       Impact factor: 10.895

10.  Trend of Antibiotic Usage for Hospitalized Community-acquired Pneumonia Cases in Korea Based on the 2010-2015 National Health Insurance Data.

Authors:  Bongyoung Kim; Rangmi Myung; Myoung Jae Lee; Jieun Kim; Hyunjoo Pai
Journal:  J Korean Med Sci       Date:  2020-12-07       Impact factor: 2.153

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.